IS7722A - Rafspunnar myndlausar lyfjablöndur - Google Patents
Rafspunnar myndlausar lyfjablöndurInfo
- Publication number
- IS7722A IS7722A IS7722A IS7722A IS7722A IS 7722 A IS7722 A IS 7722A IS 7722 A IS7722 A IS 7722A IS 7722 A IS7722 A IS 7722A IS 7722 A IS7722 A IS 7722A
- Authority
- IS
- Iceland
- Prior art keywords
- electroless
- amorphous formulations
- formulations
- amorphous
- electroless amorphous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Textile Engineering (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Optics & Photonics (AREA)
- Heart & Thoracic Surgery (AREA)
- Mechanical Engineering (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Manufacturing & Machinery (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40172602P | 2002-08-07 | 2002-08-07 | |
| PCT/US2003/024641 WO2004014304A2 (en) | 2002-08-07 | 2003-08-07 | Electrospun amorphous pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7722A true IS7722A (is) | 2005-03-01 |
Family
ID=31715724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7722A IS7722A (is) | 2002-08-07 | 2005-03-01 | Rafspunnar myndlausar lyfjablöndur |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20060013869A1 (is) |
| EP (1) | EP1534250A4 (is) |
| JP (1) | JP2005534716A (is) |
| KR (1) | KR20050055696A (is) |
| CN (1) | CN1684673A (is) |
| AR (1) | AR040820A1 (is) |
| AU (1) | AU2003258120B2 (is) |
| BR (1) | BR0313222A (is) |
| CA (1) | CA2494865A1 (is) |
| IL (1) | IL166465A0 (is) |
| IS (1) | IS7722A (is) |
| MA (1) | MA27332A1 (is) |
| MX (1) | MXPA05001499A (is) |
| NO (1) | NO20051123L (is) |
| NZ (1) | NZ537951A (is) |
| PL (1) | PL374800A1 (is) |
| RU (1) | RU2331411C2 (is) |
| TW (1) | TW200410714A (is) |
| WO (1) | WO2004014304A2 (is) |
| ZA (1) | ZA200500563B (is) |
Families Citing this family (142)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050271737A1 (en) * | 2001-06-07 | 2005-12-08 | Chinea Vanessa I | Application of a bioactive agent to a substrate |
| US20050260273A1 (en) * | 2001-06-07 | 2005-11-24 | Chinea Vanessa I | Applicatin of a bioactive agent in a solvent composition to produce a target particle morphology |
| US7767249B2 (en) * | 2001-06-07 | 2010-08-03 | Hewlett-Packard Development Company, L.P. | Preparation of nanoparticles |
| JP2005533822A (ja) | 2002-06-27 | 2005-11-10 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | 臭化水素酸カルベジロール |
| US20060083784A1 (en) * | 2002-08-07 | 2006-04-20 | Smithkline Beecham Corporation | Amorphous pharmaceutical compositions |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US8377952B2 (en) * | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| EP1686986A4 (en) * | 2003-11-25 | 2009-05-27 | Sb Pharmco Inc | CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT |
| US20080262224A1 (en) * | 2004-01-23 | 2008-10-23 | Smithkline Beecham Corporation | Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide |
| ES2245874B1 (es) * | 2004-03-22 | 2007-08-01 | Universidad De Sevilla | Procedimiento para generar nanotubos y nanofibras compuestas a partir de chorros coaxiales. |
| US20060069079A1 (en) * | 2004-09-27 | 2006-03-30 | Sever Nancy E | Stable amorphous cefdinir |
| DE102004053373A1 (de) * | 2004-11-02 | 2006-05-04 | Justus-Liebig-Universität Giessen | Erfindung betreffend anisometrische Partikel in Form von Nano-/Meso-Fasern -Röhren, -Kabeln -Bändern und deren gekrümmte oder verzweigte Abwandlungen |
| US7531503B2 (en) | 2005-03-11 | 2009-05-12 | Wake Forest University Health Sciences | Cell scaffold matrices with incorporated therapeutic agents |
| WO2006099332A2 (en) | 2005-03-11 | 2006-09-21 | Wake Forest University Health Sciences | Production of tissue engineered digits and limbs |
| EP1863546B1 (en) | 2005-03-11 | 2015-10-07 | Wake Forest University Health Sciences | Production of tissue engineered heart valves |
| CA2602029C (en) | 2005-03-11 | 2014-07-15 | Wake Forest University Health Sciences | Tissue engineered blood vessels |
| US20060204539A1 (en) | 2005-03-11 | 2006-09-14 | Anthony Atala | Electrospun cell matrices |
| CN1300393C (zh) * | 2005-07-01 | 2007-02-14 | 中国科学院长春应用化学研究所 | 超细纤维药物剂型的乳液电纺丝制备方法 |
| US8367112B2 (en) * | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
| WO2008023818A1 (fr) * | 2006-08-25 | 2008-02-28 | Sekisui Chemical Co., Ltd. | Fibre et procédé de production de fibre |
| GB0623473D0 (en) | 2006-11-24 | 2007-01-03 | Bristol Myers Squibb Co | Dissolution and processing of cellulose |
| US20100104636A1 (en) * | 2006-12-21 | 2010-04-29 | Panagiotis Keramidas | Pharmaceutical Compound and Composition |
| US20080176905A1 (en) * | 2007-01-22 | 2008-07-24 | Santiago Ini | Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| US20090326128A1 (en) * | 2007-05-08 | 2009-12-31 | Javier Macossay-Torres | Fibers and methods relating thereto |
| US20100018641A1 (en) * | 2007-06-08 | 2010-01-28 | Kimberly-Clark Worldwide, Inc. | Methods of Applying Skin Wellness Agents to a Nonwoven Web Through Electrospinning Nanofibers |
| EP2209456B1 (en) * | 2007-10-15 | 2013-03-06 | Capsugel Belgium NV | Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms |
| EP2209455A1 (en) * | 2007-10-15 | 2010-07-28 | Glaxo Group Limited | Paneled capsule shells for release of pharmaceutical compositions |
| US8293159B2 (en) * | 2007-10-15 | 2012-10-23 | Capsugel Belgium | Method and apparatus for manufacturing filled linkers |
| EA027333B1 (ru) * | 2007-10-17 | 2017-07-31 | Тодд Ф. Овокайтис | Стабильный при комнатной температуре некристаллический аспирин |
| US8765170B2 (en) | 2008-01-30 | 2014-07-01 | The Procter & Gamble Company | Personal care composition in the form of an article |
| CA2721640C (en) | 2008-04-16 | 2014-12-09 | The Procter & Gamble Company | Non-lathering personal care composition in the form of an article |
| WO2009140385A1 (en) * | 2008-05-13 | 2009-11-19 | Research Triangle Institute | Particle filter system incorporating electret nanofibers |
| WO2010015419A2 (de) | 2008-08-08 | 2010-02-11 | Basf Se | Wirkstoffhaltige fasernflächengebilde auf basis von biopolymeren, ihre anwendungen und verfahren zu ihrer herstellung |
| CN102176905A (zh) * | 2008-08-08 | 2011-09-07 | 巴斯夫欧洲公司 | 具有受控释放的活性成分的含活性成分的纤维层状结构，其用途及其生产方法 |
| CN101721751B (zh) * | 2008-10-10 | 2013-01-02 | 张阳德 | 负载了缓释细胞生长因子的具有内核的中空二氧化硅球的人体组织工程支架及其制法和用途 |
| WO2010077653A2 (en) * | 2008-12-08 | 2010-07-08 | The Procter & Gamble Company | Personal care composition in the form of an article having a hydrophobic surface-resident coating |
| US20100144228A1 (en) * | 2008-12-09 | 2010-06-10 | Branham Kelly D | Nanofibers Having Embedded Particles |
| GB2466073A (en) * | 2008-12-12 | 2010-06-16 | Univ Manchester | Tissue repair scaffold |
| WO2010071595A1 (en) * | 2008-12-19 | 2010-06-24 | Sekab Biofuels & Chemicals Ab | Denaturant-containing, ethanol-based liquid |
| US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
| GB2468503A (en) * | 2009-03-11 | 2010-09-15 | Univ Sheffield | A dressing comprising an electrospun scaffold and a nonsteroidal anti-inflammatory drug |
| GB0908433D0 (en) * | 2009-05-15 | 2009-06-24 | Glaxo Group Ltd | Movel composition |
| WO2011029777A1 (de) | 2009-09-11 | 2011-03-17 | Basf Se | Verfahren zur herstellung von beschichteten polymerfasern |
| EP2509564B1 (en) * | 2009-12-08 | 2013-11-20 | The Procter and Gamble Company | A porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres |
| EP2536871A4 (en) * | 2010-02-15 | 2013-12-18 | Univ Cornell | ELECTROFILING APPARATUS AND NANOFIBRES PRODUCED THEREWITH |
| EP2536386A1 (en) | 2010-02-16 | 2012-12-26 | The Procter & Gamble Company | A porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione |
| US20180163325A1 (en) | 2016-12-09 | 2018-06-14 | Robert Wayne Glenn, Jr. | Dissolvable fibrous web structure article comprising active agents |
| RU2541275C2 (ru) * | 2010-07-02 | 2015-02-10 | Дзе Проктер Энд Гэмбл Компани | Филаменты, содержащие неароматизированный активный агент, нетканые полотна и способы их получения |
| BR122019015741B1 (pt) * | 2010-07-02 | 2021-12-21 | The Procter & Gamble Company | Artigo de estrutura de manta fibrosa dissolvível que compreende agentes ativos |
| MX2012015171A (es) * | 2010-07-02 | 2013-05-09 | Procter & Gamble | Filamentos que comprenden un agente activo, tramas de tela no tejida y métodos para elaborarlos. |
| WO2012003319A2 (en) | 2010-07-02 | 2012-01-05 | The Procter & Gamble Company | Filaments comprising an active agent nonwoven webs and methods for making same |
| CA2803382C (en) | 2010-07-02 | 2015-03-31 | The Procter & Gamble Company | Method for delivering an active agent |
| WO2012003365A1 (en) | 2010-07-02 | 2012-01-05 | The Procter & Gamble Company | Filaments comprising an ingestible active agent nonwoven webs and methods for making same |
| EP2588589B2 (en) | 2010-07-02 | 2023-07-19 | The Procter & Gamble Company | Process for the production of a detergent product |
| WO2012103501A1 (en) * | 2011-01-28 | 2012-08-02 | Merit Medical Systems, Inc. | Electrospun ptfe coated stent and method of use |
| US9102570B2 (en) | 2011-04-22 | 2015-08-11 | Cornell University | Process of making metal and ceramic nanofibers |
| CA2834212C (en) | 2011-04-29 | 2019-05-14 | Massachusetts Institute Of Technology | Layer processing for pharmaceuticals |
| WO2012150265A1 (en) * | 2011-05-02 | 2012-11-08 | Dsm Ip Assets B.V. | Fiber comprising a biodegradable polymer |
| EP2537538A1 (en) | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbable Wound Dressing |
| CN102462673A (zh) * | 2011-07-22 | 2012-05-23 | 广东食品药品职业学院 | 一种自组装囊泡载药纳米纤维膜及其电纺制备方法 |
| RU2487701C2 (ru) * | 2011-07-26 | 2013-07-20 | Общество с ограниченной ответственностью "Инмед" | Раствор для получения материала на основе хитозана, способ получения гемостатического материала из этого раствора (варианты) и медицинское изделие с использованием волокон на основе хитозана |
| EP2751316B1 (en) | 2011-08-30 | 2017-11-29 | Cornell University | Metal and ceramic nanofibers |
| US20130237609A1 (en) * | 2011-10-19 | 2013-09-12 | Kevin J. Edgar | Cellulose derivatives for enhancing bioavailability of flavonoids |
| CN102560887B (zh) * | 2012-01-17 | 2014-01-29 | 东华大学 | 负载维生素a和e的丝素蛋白纳米纤维膜及其制备方法 |
| WO2013165604A1 (en) * | 2012-05-02 | 2013-11-07 | Massachusetts Institute Of Technology | Electroprocessing of active pharmaceutical ingredients |
| CN102631715A (zh) * | 2012-05-04 | 2012-08-15 | 江南大学 | 一种抗凝血纳米纤维膜的制备方法 |
| JP6213975B2 (ja) * | 2012-09-13 | 2017-10-18 | テイカ製薬株式会社 | 薬物含有超極細ファイバーおよびその利用 |
| EP2906189B1 (en) | 2012-10-12 | 2019-06-12 | The Procter and Gamble Company | Personal care composition in the form of a dissolvable article |
| WO2014066297A1 (en) * | 2012-10-22 | 2014-05-01 | North Carolina State University | Nonwoven fiber materials |
| JP6067342B2 (ja) * | 2012-11-16 | 2017-01-25 | 花王株式会社 | シート状化粧料 |
| US9211290B2 (en) * | 2012-12-31 | 2015-12-15 | Noven Therapeutics, Llc | Solid dispersions of amorphous paroxetine mesylate |
| CN105246469A (zh) | 2013-03-12 | 2016-01-13 | 活性纤维有限公司 | 纳米纤维和生物活性组合物及相关方法 |
| RU2522216C1 (ru) * | 2013-05-13 | 2014-07-10 | Иван Михайлович Афанасов | Многослойный материал с хитозановым слоем из нано- и ультратонких волокон |
| EP2810645B1 (en) * | 2013-06-06 | 2017-05-24 | A. Sezai Sarac | New Drug Delivery System |
| EP2813212A1 (en) * | 2013-06-10 | 2014-12-17 | Zentiva, a.s. | Drug formulation using API in nanofibers |
| TWI480071B (zh) * | 2013-06-26 | 2015-04-11 | Univ Nat Yunlin Sci & Tech | 具有三維方向性之奈米纖維細胞導管及其無毒之製備方法與應用 |
| CN103405381B (zh) * | 2013-08-23 | 2016-05-25 | 北京泰克美高新技术有限公司 | 一种制备无定型态物质的方法 |
| JP6315754B2 (ja) * | 2013-10-02 | 2018-04-25 | 花王株式会社 | シート状化粧料 |
| US10092679B2 (en) | 2013-10-18 | 2018-10-09 | Wake Forest University Health Sciences | Laminous vascular constructs combining cell sheet engineering and electrospinning technologies |
| US10653818B2 (en) | 2014-01-23 | 2020-05-19 | University Of Florida Research Foundation, Inc. | Magnetic nanoparticle embedded nanofibrous membrane |
| US20150315350A1 (en) | 2014-04-22 | 2015-11-05 | The Procter & Gamble Company | Compositions in the Form of Dissolvable Solid Structures |
| EP3134564B1 (en) * | 2014-04-22 | 2018-06-20 | The Procter and Gamble Company | Filaments and fibrous structures employing same |
| US9867762B2 (en) | 2014-05-05 | 2018-01-16 | The Procter & Gamble Company | Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating |
| US9861559B2 (en) | 2014-05-05 | 2018-01-09 | The Procter & Gamble Company | Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating |
| US9937111B2 (en) | 2014-05-05 | 2018-04-10 | The Procter & Gamble Company | Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating |
| US9827173B2 (en) | 2014-05-05 | 2017-11-28 | The Procter & Gamble Company | Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom |
| WO2015179461A1 (en) | 2014-05-20 | 2015-11-26 | Massachusetts Institute Of Technology | Plasticity induced bonding |
| US10202598B2 (en) | 2014-05-30 | 2019-02-12 | Todd Frank Ovokaitys | Methods and systems for generation, use, and delivery of activated stem cells |
| US10384985B2 (en) | 2014-06-06 | 2019-08-20 | B.K. Consultants, Inc. | Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants |
| WO2015187974A1 (en) | 2014-06-06 | 2015-12-10 | Ovokaitys Todd Frank | Methods and compositions for increasing the bioactivity of nutrients |
| CN105362269A (zh) * | 2014-09-01 | 2016-03-02 | 天津药物研究院 | 一种含蔗糖的罗氟司特片及其制备方法 |
| CN104383596A (zh) * | 2014-10-24 | 2015-03-04 | 东华大学 | 一种tpgs载药脂质体-天然材料复合纳米纤维支架的制备方法 |
| JP6606279B2 (ja) * | 2015-11-19 | 2019-11-13 | エーエフワイエックス・セラピューティクス・エー／エス | 適用部位における滞留時間が改善された、電気流体力学的に得られた繊維を含む医薬組成物 |
| RU2019126497A (ru) | 2017-01-23 | 2021-02-24 | Афикс Терапьютикс А/С | Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества |
| EP3570821B1 (en) * | 2017-01-23 | 2021-07-21 | AFYX Therapeutics A/S | Method for fabrication of a two-layered product based on electrospun fibres |
| CN110191700A (zh) | 2017-01-27 | 2019-08-30 | 宝洁公司 | 可溶性固体结构形式的组合物 |
| MX380727B (es) | 2017-01-27 | 2025-03-12 | Procter & Gamble | Composiciones en la forma de estructuras sólidas solubles que comprenden partículas aglomeradas efervescentes. |
| JP2018177724A (ja) * | 2017-04-18 | 2018-11-15 | 花王株式会社 | 外用薬 |
| JP6923673B2 (ja) | 2017-05-16 | 2021-08-25 | ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ | 溶解性固形構造体の形態のコンディショニングヘアケア組成物 |
| CN107447366A (zh) * | 2017-08-03 | 2017-12-08 | 东华大学 | 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用 |
| US11053466B2 (en) | 2018-01-26 | 2021-07-06 | The Procter & Gamble Company | Water-soluble unit dose articles comprising perfume |
| KR20200086739A (ko) | 2018-01-26 | 2020-07-17 | 더 프록터 앤드 갬블 캄파니 | 효소를 포함하는 수용성 단위 용량 물품 |
| WO2019147534A1 (en) | 2018-01-26 | 2019-08-01 | The Procter & Gamble Company | Water-soluble unit dose articles comprising perfume |
| EP3743503A1 (en) | 2018-01-26 | 2020-12-02 | The Procter & Gamble Company | Water-soluble articles and related processes |
| WO2019168829A1 (en) | 2018-02-27 | 2019-09-06 | The Procter & Gamble Company | A consumer product comprising a flat package containing unit dose articles |
| RU2671738C1 (ru) * | 2018-02-28 | 2018-11-06 | Общество с ограниченной ответственностью "Фибрасофт" | Способ получения свободно позиционируемых пленок методом электроспиннинга |
| CN108403657A (zh) * | 2018-04-04 | 2018-08-17 | 浙江大学 | 一种口服胶囊 |
| CN108635337A (zh) * | 2018-04-04 | 2018-10-12 | 浙江大学 | 一种柔性复合缓释口服胶囊 |
| CN108635336A (zh) * | 2018-04-04 | 2018-10-12 | 浙江大学 | 一种混合柔性缓释口服胶囊 |
| US11992560B2 (en) * | 2018-06-14 | 2024-05-28 | Alma Mater Studiorum—Università di Bologna | Electrospun fibers for a local release of an anti-inflammatory drug and a promyelinating drug |
| EP3583954A1 (en) * | 2018-06-19 | 2019-12-25 | neubourg skin care GmbH | Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds |
| JP1639110S (is) | 2018-07-16 | 2019-08-13 | ||
| US10982176B2 (en) | 2018-07-27 | 2021-04-20 | The Procter & Gamble Company | Process of laundering fabrics using a water-soluble unit dose article |
| US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
| US12234431B2 (en) | 2018-10-03 | 2025-02-25 | The Procter & Gamble Company | Water-soluble unit dose articles comprising water-soluble fibrous structures and particles |
| CN113748195B (zh) | 2019-01-28 | 2024-01-19 | 宝洁公司 | 可回收利用的、可再生的或可生物降解的包装 |
| CN113544249A (zh) | 2019-03-19 | 2021-10-22 | 宝洁公司 | 减少织物上的恶臭的方法 |
| EP3712237A1 (en) | 2019-03-19 | 2020-09-23 | The Procter & Gamble Company | Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures |
| CN114206307B (zh) | 2019-06-28 | 2024-08-23 | 宝洁公司 | 包含阴离子表面活性剂的可溶性固体纤维制品 |
| WO2021003492A1 (en) | 2019-07-03 | 2021-01-07 | The Procter & Gamble Company | Fibrous structures containing cationic surfactants and soluble acids |
| USD939359S1 (en) | 2019-10-01 | 2021-12-28 | The Procter And Gamble Plaza | Packaging for a single dose personal care product |
| US11597191B2 (en) | 2019-10-14 | 2023-03-07 | The Procter & Gamble Company | Biodegradable and/or home compostable sachet containing a solid article |
| CA3157576A1 (en) | 2019-11-20 | 2021-05-27 | The Procter & Gamble Company | Porous dissolvable solid structure |
| JP7617104B2 (ja) | 2019-12-01 | 2025-01-17 | ザ プロクター アンド ギャンブル カンパニー | 安息香酸ナトリウム、並びにグリコール及び／又はグリセリルエステルを含有する防腐剤系を有する、ヘアコンディショナー組成物 |
| CN111020880A (zh) * | 2019-12-04 | 2020-04-17 | 广西民族大学 | 结肠靶向盐酸青藤碱缓释纳米纤维膜及其制备方法和应用 |
| USD941051S1 (en) | 2020-03-20 | 2022-01-18 | The Procter And Gamble Company | Shower hanger |
| USD962050S1 (en) | 2020-03-20 | 2022-08-30 | The Procter And Gamble Company | Primary package for a solid, single dose beauty care composition |
| USD965440S1 (en) | 2020-06-29 | 2022-10-04 | The Procter And Gamble Company | Package |
| WO2022027067A1 (en) | 2020-07-31 | 2022-02-03 | The Procter & Gamble Company | Water-soluble fibrous pouch containing prills for hair care |
| CN116456957A (zh) | 2020-08-11 | 2023-07-18 | 宝洁公司 | 含有芸苔油醇缬氨酸酯乙磺酸盐的低粘度毛发调理剂组合物 |
| MX2023001045A (es) | 2020-08-11 | 2023-02-16 | Procter & Gamble | Composiciones acondicionadoras humectantes para el cabello que contienen esilato de valinato de brassicilo. |
| WO2022036352A1 (en) | 2020-08-11 | 2022-02-17 | The Procter & Gamble Company | Clean rinse hair conditioner compositions containing brassicyl valinate esylate |
| JP7605842B2 (ja) | 2020-08-19 | 2024-12-24 | ザ プロクター アンド ギャンブル カンパニー | 直接添加マイクロカプセルを含有する可撓性多孔質溶解性固体シート物品及びそれを作製するための方法 |
| EP4255384A1 (en) | 2020-12-01 | 2023-10-11 | The Procter & Gamble Company | Aqueous hair conditioner compositions containing solubilized anti-dandruff actives |
| JP2023552806A (ja) | 2020-12-08 | 2023-12-19 | フランク オヴォカイツ トッド | 幹細胞の増産のための方法およびシステム |
| USD1045064S1 (en) | 2020-12-17 | 2024-10-01 | The Procter & Gamble Company | Single-dose dissolvable personal care unit |
| WO2023034763A1 (en) | 2021-08-30 | 2023-03-09 | The Procter & Gamble Company | Dissolvable solid structure comprising first and second polymeric structurants |
| WO2023117590A1 (en) * | 2021-12-21 | 2023-06-29 | Universiteit Gent | Solution electrospun fibers, compositions comprising the same and a process of manufacturing thereof |
| JPWO2023145886A1 (is) * | 2022-01-31 | 2023-08-03 | ||
| CN114522166B (zh) * | 2022-04-22 | 2022-09-30 | 北京剂泰医药科技有限公司 | 一种固体分散体组合物及其制备方法和应用 |
| CN116898820A (zh) * | 2023-07-12 | 2023-10-20 | 浙江亚瑟医药有限公司 | 一种基于静电纺丝技术制备环孢素固体分散体的方法 |
| CN118750469B (zh) * | 2024-06-12 | 2025-09-26 | 华中农业大学 | 一种尺寸可控的噬菌体水凝胶微球及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US17208A (en) * | 1857-05-05 | Improvement in heating feed-water apparatus of locomotives | ||
| US5034421A (en) * | 1988-12-13 | 1991-07-23 | Fuisz Pharmaceutical Ltd. | Moderated spun fibrous system and method of manufacture |
| US5024789A (en) * | 1988-10-13 | 1991-06-18 | Ethicon, Inc. | Method and apparatus for manufacturing electrostatically spun structure |
| US5311884A (en) * | 1991-11-12 | 1994-05-17 | Ethicon, Inc. | Process for making a piezoelectric biomedical device |
| US5567439A (en) * | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US5980941A (en) * | 1997-08-20 | 1999-11-09 | Fuisz Technologies Ltd. | Self-binding shearform compositions |
| US6106913A (en) * | 1997-10-10 | 2000-08-22 | Quantum Group, Inc | Fibrous structures containing nanofibrils and other textile fibers |
| US6110590A (en) * | 1998-04-15 | 2000-08-29 | The University Of Akron | Synthetically spun silk nanofibers and a process for making the same |
| US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
| PL356924A1 (en) * | 2000-01-28 | 2004-07-12 | Smithkline Beecham Corporation | Electrospun pharmaceutical compositions |
| WO2002032397A2 (en) * | 2000-10-18 | 2002-04-25 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessing in drug delivery and cell encapsulation |
| WO2003099230A2 (en) * | 2002-05-28 | 2003-12-04 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
-
2003
- 2003-08-05 TW TW092121421A patent/TW200410714A/zh unknown
- 2003-08-07 AR AR20030102846A patent/AR040820A1/es not_active Application Discontinuation
- 2003-08-07 NZ NZ537951A patent/NZ537951A/en unknown
- 2003-08-07 PL PL03374800A patent/PL374800A1/xx not_active Application Discontinuation
- 2003-08-07 AU AU2003258120A patent/AU2003258120B2/en not_active Expired - Fee Related
- 2003-08-07 RU RU2005106261/15A patent/RU2331411C2/ru not_active IP Right Cessation
- 2003-08-07 BR BR0313222-6A patent/BR0313222A/pt not_active IP Right Cessation
- 2003-08-07 JP JP2004527797A patent/JP2005534716A/ja active Pending
- 2003-08-07 MX MXPA05001499A patent/MXPA05001499A/es unknown
- 2003-08-07 CN CNA038232375A patent/CN1684673A/zh active Pending
- 2003-08-07 EP EP03784959A patent/EP1534250A4/en not_active Withdrawn
- 2003-08-07 US US10/523,835 patent/US20060013869A1/en not_active Abandoned
- 2003-08-07 KR KR1020057002071A patent/KR20050055696A/ko not_active Ceased
- 2003-08-07 CA CA002494865A patent/CA2494865A1/en not_active Abandoned
- 2003-08-07 WO PCT/US2003/024641 patent/WO2004014304A2/en not_active Ceased
-
2005
- 2005-01-20 ZA ZA200500563A patent/ZA200500563B/xx unknown
- 2005-01-24 IL IL16646505A patent/IL166465A0/xx unknown
- 2005-02-04 MA MA28092A patent/MA27332A1/fr unknown
- 2005-03-01 IS IS7722A patent/IS7722A/is unknown
- 2005-03-02 NO NO20051123A patent/NO20051123L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2331411C2 (ru) | 2008-08-20 |
| WO2004014304A2 (en) | 2004-02-19 |
| IL166465A0 (en) | 2006-01-15 |
| KR20050055696A (ko) | 2005-06-13 |
| EP1534250A2 (en) | 2005-06-01 |
| PL374800A1 (en) | 2005-10-31 |
| MA27332A1 (fr) | 2005-05-02 |
| NO20051123L (no) | 2005-05-06 |
| CA2494865A1 (en) | 2004-02-19 |
| NZ537951A (en) | 2007-12-21 |
| ZA200500563B (en) | 2006-07-26 |
| CN1684673A (zh) | 2005-10-19 |
| TW200410714A (en) | 2004-07-01 |
| RU2005106261A (ru) | 2005-08-10 |
| JP2005534716A (ja) | 2005-11-17 |
| EP1534250A4 (en) | 2007-07-04 |
| MXPA05001499A (es) | 2005-04-19 |
| AU2003258120A1 (en) | 2004-02-25 |
| BR0313222A (pt) | 2005-06-14 |
| US20060013869A1 (en) | 2006-01-19 |
| AR040820A1 (es) | 2005-04-20 |
| WO2004014304A3 (en) | 2004-06-24 |
| AU2003258120B2 (en) | 2009-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7722A (is) | Rafspunnar myndlausar lyfjablöndur | |
| DE50311485D1 (de) | Sämaschine | |
| DE50313587D1 (de) | Sämaschine | |
| DE60231431D1 (de) | Ement | |
| NO20032486L (no) | Analytt-testeanordning | |
| DE60325530D1 (de) | Repositionsvorrichtung | |
| DE60315809D1 (de) | Geformtes tampon | |
| DE50307455D1 (de) | Einstellsystem | |
| BR0313322B1 (pt) | escova de dentes | |
| NO20044046L (no) | Substituerte hydroksyetylaminer | |
| DE60311524D1 (de) | Zahnbürste | |
| DE60324360D1 (de) | Zuführvorrichtung | |
| DE50302630D1 (de) | Verstellantrieb | |
| DE50305428D1 (de) | Objekt-selbstschutzvorrichtung | |
| DE60326998D1 (de) | Orale zubereitung | |
| ATE496887T1 (de) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide | |
| DE60324491D1 (de) | Kultivator | |
| DE50303220D1 (de) | Sämaschine | |
| DE60330436D1 (de) | Kultivierungsvorrichtung | |
| DE50312758D1 (de) | Zugöse | |
| DE60324196D1 (de) | Narcistatin-prodrugs | |
| DE60331362D1 (de) | Zugantriebskraft-übertragungsvorrichtung | |
| NO20032637D0 (no) | Tannbörste | |
| EP1406396A4 (en) | Receiving apparatus | |
| ITUD20020130A1 (it) | Dispositivo di trasmissione |